Patients
Have you been diagnosed with cancer?
With many cancers, genetic testing is recommended at the time of diagnosis. Genetic testing reveals important features, including mutations and other specific markers for treatment response. Some of these features can be targeted by therapies. The results from your genetic testing can help your provider personalize treatment plans to target specific features of your cancer.
Our commitment
BostonGene’s mission is to power healthcare’s transition to personalized medicine using our AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics.
What sets BostonGene apart?
Every cancer and every patient is unique. Our approach uncovers unique features of each tumor enabling doctors to design the best treatment for your cancer. BostonGene is the first and only company to use a comprehensive artificial intelligence-based platform to holistically analyze each tumor, the area around the tumor, and immunity to uncover treatable targets unique to you to personalize your therapy.
Our approach
Using artificial intelligence and next-generation DNA and RNA sequencing, the BostonGene Tumor Portrait™ Test provides the most accurate and comprehensive view of your tumor’s biology and its interaction with your immune system.
Tumor Portrait™ Test
Your BostonGene Tumor Portrait™ Test report provides important information including tumor composition, what genes drive your tumor’s growth, how your immune system is responding to the tumor, treatment recommendations, and potentially beneficial clinical trials.
Liquid biopsy
BostonGene’s Liquid Biopsy test covers all genes recommended by the National Comprehensive Cancer Network, including those most relevant to patient care providing physicians with a complete genomic profile from a single blood sample. Our clinical test detects all types of biomarkers including single nucleotide polymorphisms (SNPs) / indels (somatic), copy number alterations (CNAs), rearrangements, microsatellite instability (MSI) status.
Integrated genomic registry
At BostonGene, we are committed to advancing the landscape of cancer research. We welcome all eligible patients to participate in our BostonGene-Integrated Genomic Registry (BIGR) study to improve outcomes for future cancer patients. Contact us to learn more.
Financial assistance
BostonGene financial assistance
BostonGene is committed to working with your financial situation and finding a way to make our tests affordable. We have designed a Financial Assistance program that could offer a better understanding of what your maximum out-of-pocket cost would be and allow you some financial flexibility. We encourage you to apply for financial assistance prior to the test administration, but if you don’t, the program is available to you at any point of the journey. The program covers longitudinal testing for up to 18 months.
Application process
Applications are processed within 1-2 business days and the results will be communicated by the preferred method indicated on the application.
Billing process
We will bill your insurance first and the qualified assistance will be applied to any balance deemed as the patient’s responsibility after insurance processes our claim. Please note that once a claim is submitted to your insurance, you might receive an Explanation of Benefits (EOB). THIS IS NOT A BILL. We will work with your insurance to get the best coverage for you, including filing an appeal on your behalf in case of a denial. For questions and concerns about billing, contact us at +1 781-552-3131, option 2.
Eligibility
All U.S.-based patients are eligible to apply for assistance. The financial assistance program is currently not available to international patients. However, we provide a discounted self-pay price and are able to work out an affordable payment plan to fit into your financial situation.
BostonGene helps personalize your cancer care with next generation sequencing analysis. We perform a test on your normal DNA (blood) and tumor DNA and RNA (tissue) that gives your physicians information about how to optimize your treatment based on the specific changes in your cancer. This type of testing can answer questions like what changes in your cells are driving your cancer and lists targeted treatment options that are tailored to you.
The BostonGene report is delivered to your physician. The report will include the following information:
Genetic alterations detected in your tumor
Therapy recommendations
Available clinical trials
After comprehensive analysis is performed at BostonGene, your physician will receive the test results, which they will discuss with you.